227 related articles for article (PubMed ID: 27241955)
21. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
[TBL] [Abstract][Full Text] [Related]
22. Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland.
Favrod-Coune T; Baroudi M; Casillas A; Rieder JP; Gétaz L; Barro J; Gaspoz JM; Broers B; Wolff H
Swiss Med Wkly; 2013; 143():w13898. PubMed ID: 24186493
[TBL] [Abstract][Full Text] [Related]
23. A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.
Larney S; Zador D; Sindicich N; Dolan K
Drug Alcohol Rev; 2017 May; 36(3):305-310. PubMed ID: 27325289
[TBL] [Abstract][Full Text] [Related]
24. Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study.
Grebely J; Alavi M; Micallef M; Dunlop AJ; Balcomb AC; Phung N; Weltman MD; Day CA; Treloar C; Bath N; Haber PS; Dore GJ;
Addiction; 2016 Feb; 111(2):311-9. PubMed ID: 26451534
[TBL] [Abstract][Full Text] [Related]
25. The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia.
Butler K; Day C; Dietze P; Bruno R; Alati R; Burns L
J Subst Abuse Treat; 2015 Nov; 58():90-4. PubMed ID: 26117080
[TBL] [Abstract][Full Text] [Related]
26. Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study.
Larney S; Gisev N; Farrell M; Dobbins T; Burns L; Gibson A; Kimber J; Degenhardt L
BMJ Open; 2014 Apr; 4(4):e004666. PubMed ID: 24694626
[TBL] [Abstract][Full Text] [Related]
27. Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy.
Spada E; Rezza G; Garbuglia AR; Lombardo FL; Zuccaro O; Menniti Ippolito F; Cupellaro E; Capone S; Capobianchi MR; Nicosia A; Cortese R; Folgori A; Mele A;
J Urban Health; 2018 Feb; 95(1):99-110. PubMed ID: 29204843
[TBL] [Abstract][Full Text] [Related]
28. Opioid substitution therapy is associated with increased detection of hepatitis C virus infection: a 15-year observational cohort study.
Larney S; Grebely J; Falster M; Swart A; Amin J; Degenhardt L; Burns L; Vajdic CM
Drug Alcohol Depend; 2015 Mar; 148():213-6. PubMed ID: 25578251
[TBL] [Abstract][Full Text] [Related]
29. Impact of opioid substitution therapy for Scotland's prisoners on drug-related deaths soon after prisoner release.
Bird SM; Fischbacher CM; Graham L; Fraser A
Addiction; 2015 Oct; 110(10):1617-24. PubMed ID: 25940815
[TBL] [Abstract][Full Text] [Related]
30. Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment.
Kimber J; Copeland L; Hickman M; Macleod J; McKenzie J; De Angelis D; Robertson JR
BMJ; 2010 Jul; 341():c3172. PubMed ID: 20595255
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of opioid substitution therapy utilisation among opioid-dependent men and women.
Gisev N; Degenhardt L; Larney S; Larance B; Gibson A; Kimber J; Burns L
Drug Alcohol Rev; 2014 Sep; 33(5):499-505. PubMed ID: 24840554
[TBL] [Abstract][Full Text] [Related]
32. Non drug-related and opioid-specific causes of 3262 deaths in Scotland's methadone-prescription clients, 2009-2015.
Gao L; Robertson JR; Bird SM
Drug Alcohol Depend; 2019 Apr; 197():262-270. PubMed ID: 30875647
[TBL] [Abstract][Full Text] [Related]
33. DYNAMICS OF OPIOID SUBSTITUTION TREATMENTIN DIFFERENT INITIAL SUBSTANCE USER OPIOID DEPENDENT PATIENTS.
Todadze Kh; Mosia S
Georgian Med News; 2016 May; (254):56-61. PubMed ID: 27348169
[TBL] [Abstract][Full Text] [Related]
34. [Evolution of the need and coverage of opioid substitution treatments and needle exchange programmes in Spanish prisons, 1992-2009].
de la Fuente L; Bravo MJ; Jiménez-Mejías E; Sordo L; Pulido J; Barrio G
Rev Esp Sanid Penit; 2012; 14(2):67-77. PubMed ID: 22801652
[TBL] [Abstract][Full Text] [Related]
35. Non-prescribed use of opioid substitution medication: Patterns and trends in sub-populations of opioid users in Germany.
Schulte B; Schmidt CS; Strada L; Götzke C; Hiller P; Fischer B; Reimer J
Int J Drug Policy; 2016 Mar; 29():57-65. PubMed ID: 26818083
[TBL] [Abstract][Full Text] [Related]
36. Risk of anaphylaxis in opioid dependent persons: effects of heroin versus substitution substance.
Maurer U; Kager C; Fellinger C; Loader D; Pollesböck A; Spitzer B; Jarisch R
Subst Abuse Treat Prev Policy; 2014 Feb; 9():12. PubMed ID: 24576327
[TBL] [Abstract][Full Text] [Related]
37. Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: comparison of Indigenous and non-Indigenous Australians.
Gisev N; Gibson A; Larney S; Kimber J; Williams M; Clifford A; Doyle M; Burns L; Butler T; Weatherburn DJ; Degenhardt L
BMC Public Health; 2014 Sep; 14():920. PubMed ID: 25192713
[TBL] [Abstract][Full Text] [Related]
38. Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates.
Barrio G; Bravo MJ; Brugal MT; Díez M; Regidor E; Belza MJ; de la Fuente L;
Addiction; 2012 Jun; 107(6):1111-22. PubMed ID: 22151686
[TBL] [Abstract][Full Text] [Related]
39. Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10.
Evans E; Li L; Min J; Huang D; Urada D; Liu L; Hser YI; Nosyk B
Addiction; 2015 Jun; 110(6):996-1005. PubMed ID: 25644938
[TBL] [Abstract][Full Text] [Related]
40. Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs.
Treloar C; Hull P; Dore GJ; Grebely J
Drug Alcohol Rev; 2012 Nov; 31(7):918-24. PubMed ID: 22612899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
